Home » Medical Devices » Neurovascular Devices Market

Neurovascular Devices Market By Device (Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices); By Application (Stroke, Cerebral Artery Stenosis, Cerebral Aneurysm, Others); By End-use (Hospitals, Specialty Clinics, Others); By Size (0.027″, 0.021″, 0.071″, 0.017″, 0.019″, 0.013″, 0.058″, 0.068″, Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $4699

Published: | Report ID: 14457 | Report Format : Excel, PDF
REPORT ATTRIBUTE DETAILS
Historical Period 2020-2023
Base Year 2024
Forecast Period 2025-2032
Neurovascular Devices Market Size 2024 USD 7,851.39 million
Neurovascular Devices Market, CAGR 5.80%
Neurovascular Devices Market Size 2032 USD 12,298.26 million

Market Overview

Neurovascular Devices Market size was valued at USD 6,780.00 million in 2018 to USD 7,851.39 million in 2024 and is anticipated to reach USD 12,298.26 million by 2032, at a CAGR of 5.80% during the forecast period.

The Neurovascular Devices Market is experiencing robust growth driven by the rising incidence of neurovascular diseases such as stroke and aneurysms, coupled with an aging global population that is increasingly susceptible to these conditions. Advancements in minimally invasive surgical techniques and the development of technologically advanced devices, including stent retrievers and flow diverters, are significantly improving patient outcomes and boosting adoption among healthcare providers. Heightened awareness of early diagnosis and treatment options, along with supportive government initiatives and increased healthcare spending, further accelerate market expansion. Trends indicate a growing preference for endovascular procedures due to reduced recovery times and complications, as well as ongoing investments in research and development to introduce more efficient, safer, and cost-effective solutions. The integration of artificial intelligence and advanced imaging in neurovascular procedures is also enhancing procedural accuracy, signaling a continued shift toward innovation and improved clinical results in the neurovascular devices sector.

The geographical analysis of the Neurovascular Devices Market highlights strong growth across North America, Europe, and Asia Pacific, with each region contributing uniquely to the industry’s expansion. North America stands out for its robust healthcare infrastructure, early adoption of advanced neurovascular technologies, and presence of major manufacturers. Europe’s growth is supported by an increasing prevalence of neurovascular disorders, well-established medical networks, and ongoing clinical research. Asia Pacific demonstrates significant momentum due to expanding healthcare investment, a large patient pool, and rapid technological advancement in countries such as China, Japan, and India. Among the leading companies driving innovation and market presence are Medtronic, Stryker Corporation, and Terumo Corporation. These key players invest heavily in research and development, consistently launch new products, and maintain strong collaborations with healthcare providers and academic institutions to support global market advancement.

Market Insights

      The Neurovascular Devices Market is projected to grow from USD 7,851.39 million in 2024 to USD 12,298.26 million by 2032, registering a CAGR of 5.80% during the forecast period.

·       Rising incidence of stroke, cerebral aneurysms, and other neurovascular disorders is a key factor driving demand for advanced neurovascular devices worldwide.

·       Minimally invasive procedures, digital integration, and adoption of artificial intelligence in device design are major trends reshaping the landscape and improving patient outcomes.

·       Leading companies such as Medtronic, Stryker Corporation, and Terumo Corporation hold strong positions in the market by continuously launching innovative devices and expanding their global reach.

·       High device costs, stringent regulatory processes, and limited access to specialized neurovascular care in emerging regions remain significant restraints for market expansion.

·       North America leads the market due to its developed healthcare infrastructure and rapid adoption of cutting-edge technologies, while Asia Pacific is witnessing accelerated growth driven by large patient populations and increasing healthcare investments.

·       The competitive environment is characterized by strategic collaborations, mergers and acquisitions, and a focus on research and development to maintain technological leadership and address evolving clinical needs.

Design Element 2

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

CTA Design Element 3

Market Drivers

Rising Prevalence of Neurovascular Disorders and Aging Population Fuels Demand

The increasing prevalence of neurovascular disorders, such as stroke, aneurysms, and arteriovenous malformations, remains a primary driver for the Neurovascular Devices Market. It benefits from a rapidly aging population that faces a higher risk of these conditions due to age-related physiological changes. Epidemiological studies highlight a steady rise in stroke cases globally, propelling the demand for advanced intervention and treatment solutions. Growing awareness about early diagnosis and the availability of effective neurovascular devices is encouraging more patients to seek timely care. Public health initiatives and awareness campaigns support this trend by educating populations about the risk factors and symptoms of neurovascular diseases. The rising burden of neurological diseases strengthens the need for specialized devices, ensuring sustained market expansion.

  • For instance, the World Health Organization has highlighted in its recent reports that the burden of stroke continues to grow, especially in regions with expanding elderly populations.

Advancements in Minimally Invasive Technologies Improve Patient Outcomes

Continuous technological advancements in minimally invasive procedures play a significant role in shaping the Neurovascular Devices Market. It experiences strong adoption of devices such as stent retrievers, flow diverters, and embolic coils that enable precise interventions with minimal trauma. Healthcare providers prefer these solutions because they reduce hospital stays, lower complication rates, and enhance patient recovery times. The shift toward endovascular techniques over traditional open surgeries reflects a broader industry movement prioritizing patient safety and quality of care. New product approvals and regulatory clearances for innovative neurovascular devices enable wider clinical adoption. The commitment to advancing device technology creates new opportunities for market participants.

  • For instance, several leading medical device companies have introduced new-generation stent retrievers and flow diverters that have received positive feedback from interventional neurologists for their ease of use and clinical effectiveness.

Increased Healthcare Investments and Favorable Government Policies Support Growth

Greater investments in healthcare infrastructure, especially in emerging economies, provide a foundation for the Neurovascular Devices Market. It benefits from government policies aimed at improving access to advanced medical technologies and strengthening public health systems. Expansion of specialized neurovascular care centers, along with rising insurance coverage for neurovascular procedures, increases the uptake of these devices. Public-private partnerships are facilitating the deployment of new technologies and expanding treatment availability in underserved regions. The presence of funding for research and development encourages manufacturers to innovate and enhance their product portfolios. Robust healthcare funding and policy support will continue to underpin market growth.

Integration of Artificial Intelligence and Advanced Imaging Drives Innovation

The integration of artificial intelligence (AI) and advanced imaging technologies is transforming the Neurovascular Devices Market. It allows for greater procedural precision, faster diagnosis, and better patient stratification. AI-driven platforms are assisting clinicians in decision-making by providing real-time data analysis and risk assessment. Innovations in imaging, such as 3D visualization and high-resolution angiography, improve the accuracy of device placement and treatment planning. These technologies are reducing procedure times and optimizing clinical workflows, leading to improved outcomes and higher efficiency. The ongoing digital transformation in healthcare ensures the market remains at the forefront of medical innovation.

Market Trends

Expansion of Minimally Invasive and Image-Guided Procedures Continues to Accelerate

A key trend in the Neurovascular Devices Market involves the widespread adoption of minimally invasive and image-guided procedures. It benefits from the preference among clinicians and patients for less invasive solutions that promise faster recovery and lower complication rates. New product launches featuring advanced navigation systems and microcatheters are setting new standards for procedural precision. Enhanced imaging capabilities support surgeons in accurately targeting lesions and improving patient outcomes. The growing availability of hybrid operating rooms and interventional suites further accelerates this shift. Health systems are investing in specialized training to expand access to these techniques and to support the integration of innovative devices.

  • For instance, recent hospital surveys in North America and Asia-Pacific have reported a marked increase in the use of advanced navigation systems and microcatheters in neurovascular interventions.

Development of Next-Generation Devices Focuses on Safety and Efficacy

Manufacturers are prioritizing the development of next-generation neurovascular devices designed to enhance safety and clinical efficacy. The Neurovascular Devices Market features products with improved biocompatibility, durability, and flexibility, enabling more complex interventions in challenging anatomies. Research and development efforts are yielding stents, coils, and embolic agents with enhanced deployment accuracy and reduced risk of complications. The trend toward personalized devices tailored for specific patient profiles continues to strengthen. Clinical data supporting the efficacy of these new devices is driving regulatory approvals and adoption. Manufacturers are leveraging user feedback to address unmet clinical needs and optimize device performance.

  • For instance, recent clinical trials sponsored by leading device manufacturers have demonstrated the benefits of new embolic agents and stents with improved biocompatibility and deployment accuracy.

Strategic Collaborations and Mergers Drive Product Innovation and Market Reach

Strategic collaborations, mergers, and acquisitions are shaping the competitive landscape of the Neurovascular Devices Market. It enables industry players to expand product portfolios, access novel technologies, and enter new geographies. Companies are entering into alliances with research institutions and startups to accelerate the development and commercialization of innovative devices. Partnerships with hospitals and academic centers are facilitating large-scale clinical trials and evidence generation. These strategies help firms adapt to evolving market demands and capitalize on growth opportunities. The dynamic nature of the industry encourages continuous investment in research and commercialization.

Emphasis on Digital Integration and Data-Driven Decision Making Gains Momentum

Digital integration and data-driven decision making have become prominent trends within the Neurovascular Devices Market. It now incorporates artificial intelligence, machine learning, and advanced data analytics into clinical workflows. These technologies enable clinicians to enhance diagnostic accuracy, monitor patient progress, and optimize treatment protocols. The use of real-time data is supporting precision medicine and personalized therapy planning. Digital health platforms are facilitating remote monitoring and post-procedure care, improving patient engagement and outcomes. The market demonstrates a clear movement toward technology-enabled, value-based healthcare delivery.

Market Challenges Analysis

Complex Regulatory Landscape and High Cost of Innovation Hinder Market Growth

The complex regulatory landscape presents a significant challenge for the Neurovascular Devices Market. It faces strict approval requirements and rigorous clinical validation processes across global markets. Meeting these demands requires substantial investments of time and resources, often slowing product launches and limiting access to innovative devices. High development costs and the need for extensive safety and efficacy data further add to the financial burden on manufacturers. Smaller companies may struggle to compete due to limited capital and regulatory expertise. The complexity of global compliance standards can lead to delays and increased operational risk for market participants.

  • For instance, surveys conducted by industry associations have found that manufacturers often cite the need to comply with multiple regulatory frameworks such as those set by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) as a major hurdle.

Limited Access to Specialized Care and Variability in Reimbursement Impede Adoption

Limited access to specialized neurovascular care and inconsistencies in reimbursement policies remain persistent challenges for the Neurovascular Devices Market. It faces disparities in healthcare infrastructure, particularly in emerging and rural regions where advanced neurovascular centers are scarce. Variability in reimbursement coverage can create uncertainty for both providers and patients, impacting the adoption of new technologies. Training gaps among healthcare professionals may hinder optimal device utilization and procedural success. Budget constraints within healthcare systems often restrict investment in state-of-the-art equipment. These factors contribute to uneven market penetration and slow the uptake of innovative neurovascular solutions.

Market Opportunities

Emerging Markets and Expanding Healthcare Infrastructure Create New Growth Avenues

The expansion of healthcare infrastructure in emerging markets presents substantial opportunities for the Neurovascular Devices Market. It stands to benefit from increased investment in hospitals, specialized stroke centers, and advanced imaging facilities in developing countries. Government initiatives and international collaborations are driving efforts to improve access to neurovascular care and address the rising burden of stroke and related disorders. As awareness and diagnosis rates improve, the demand for neurovascular devices is expected to rise in these regions. Companies that tailor product offerings and distribution strategies to local needs can gain a significant competitive edge. The presence of a large, underserved patient population offers considerable potential for future market growth.

Innovation in Digital Technologies and Personalized Medicine Supports Market Expansion

Ongoing innovation in digital health technologies and personalized medicine represents a strong opportunity for the Neurovascular Devices Market. It is poised to leverage artificial intelligence, machine learning, and remote monitoring solutions to enhance patient outcomes and streamline clinical workflows. Personalized approaches to neurovascular treatment are driving the development of tailored devices and data-driven therapy planning. Collaboration with technology firms and academic institutions will accelerate the adoption of smart neurovascular devices. Digital platforms that enable telemedicine and patient engagement can further extend market reach. These advances hold promise for improving procedural success rates and transforming standards of neurovascular care.

Market Segmentation Analysis:

By Device:

cerebral embolization and aneurysm coiling devices lead due to their critical role in treating cerebral aneurysms and complex vascular abnormalities. These devices enable minimally invasive procedures, which appeal to clinicians seeking to reduce patient risk and recovery time. Cerebral angioplasty and stenting systems follow, driven by their effectiveness in managing cerebral artery stenosis and restoring adequate blood flow to the brain. Neurothrombectomy devices hold a strong position due to rising stroke incidence worldwide, offering rapid clot removal and improved outcomes for acute ischemic stroke patients. Support devices complement these categories, enhancing procedural efficiency and safety.

By Application:

The market also segments by application, with stroke commanding the largest share. It reflects the global rise in stroke prevalence and ongoing demand for prompt, effective intervention. Cerebral artery stenosis represents another significant application area, requiring precise device deployment for optimal patient management. Cerebral aneurysm treatment continues to see strong device adoption, benefiting from technological advances and early diagnosis rates. The “others” segment captures use in conditions such as arteriovenous malformations and vascular malformations, where innovative neurovascular devices support tailored therapy.

By End-use:

End-use segmentation further shapes market structure, with hospitals representing the primary channel for neurovascular device adoption. Hospitals leverage advanced imaging, specialized neurology teams, and comprehensive acute care infrastructure to deliver complex neurovascular interventions. Specialty clinics show growing demand, particularly in regions investing in ambulatory surgical centers and specialized neurology practices. The “others” category includes academic and research institutions, which play a vital role in early-stage device trials and the advancement of neurovascular treatment protocols. Each segment, through focused adoption and clinical integration, supports sustained growth and technological innovation within the Neurovascular Devices Market.

Segments:

Based on Device:

  • Cerebral Embolization and Aneurysm Coiling Devices
  • Cerebral Angioplasty and Stenting Systems
  • Neurothrombectomy Devices
  • Support Devices

Based on Application:

  • Stroke
  • Cerebral Artery Stenosis
  • Cerebral Aneurysm
  • Others

Based on End-use:

  • Hospitals
  • Specialty Clinics
  • Others

Based on Size:

  • 0.027″
  • 0.021″
  • 0.071″
  • 0.017″
  • 0.019″
  • 0.013″
  • 0.058″
  • 0.068″
  • Others

Based on the Geography:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Russia
    • Belgium
    • Netherlands
    • Austria
    • Sweden
    • Poland
    • Denmark
    • Switzerland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Thailand
    • Indonesia
    • Vietnam
    • Malaysia
    • Philippines
    • Taiwan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Peru
    • Chile
    • Colombia
    • Rest of Latin America
  • Middle East
    • UAE
    • KSA
    • Israel
    • Turkey
    • Iran
    • Rest of Middle East
  • Africa
    • Egypt
    • Nigeria
    • Algeria
    • Morocco
    • Rest of Africa

Regional Analysis

North America Neurovascular Devices Market

North America Neurovascular Devices Market grew from USD 2,206.21 million in 2018 to USD 2,532.26 million in 2024 and is projected to reach USD 3,981.60 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.9%. North America is holding a 32% market share. The United States and Canada dominate the region due to robust healthcare infrastructure, early adoption of advanced neurovascular technologies, and the presence of leading industry players. The region benefits from extensive reimbursement systems, large patient populations, and strong investments in research and clinical trials. Demand for minimally invasive treatments and a high incidence of stroke and aneurysms are driving device utilization. Hospitals and specialized neurology centers in the U.S. and Canada remain central to market expansion.

Europe Neurovascular Devices Market

Europe Neurovascular Devices Market grew from USD 1,635.34 million in 2018 to USD 1,813.46 million in 2024 and is expected to reach USD 2,643.79 million by 2032, at a CAGR of 4.9%. Europe accounts for a 22% market share. Key countries including Germany, France, and the United Kingdom contribute significantly due to a high prevalence of neurovascular diseases and a strong focus on healthcare quality. European nations benefit from regulatory support, public health initiatives, and a growing emphasis on advanced diagnostic and therapeutic technologies. Aging populations and well-established medical networks support device demand. Regional collaborations and clinical research further accelerate market penetration.

Asia Pacific Neurovascular Devices Market

Asia Pacific Neurovascular Devices Market grew from USD 1,722.12 million in 2018 to USD 2,055.02 million in 2024 and is set to reach USD 3,635.47 million by 2032, posting a CAGR of 7.5%. Asia Pacific represents a 30% market share. China, Japan, and India lead growth with rapidly evolving healthcare infrastructure, rising incidence of cerebrovascular diseases, and increasing investments in hospitals and medical technology. Government initiatives, expanding insurance coverage, and greater awareness of early intervention are driving device uptake. Local manufacturers are introducing cost-effective devices tailored to regional needs, fueling competition and growth. The large patient pool offers significant opportunities for further expansion.

Latin America Neurovascular Devices Market

Latin America Neurovascular Devices Market grew from USD 776.31 million in 2018 to USD 894.19 million in 2024 and is anticipated to reach USD 1,334.73 million by 2032, at a CAGR of 5.2%. Latin America holds a 11% market share. Brazil, Mexico, and Argentina anchor the region with increased healthcare investments and the expansion of stroke care programs. Efforts to upgrade hospital capabilities and broaden access to neurovascular interventions are propelling market development. Public-private partnerships and international collaborations support technology transfer and medical training. Market players are targeting emerging urban centers to capitalize on growing demand.

Middle East Neurovascular Devices Market

Middle East Neurovascular Devices Market grew from USD 241.37 million in 2018 to USD 260.62 million in 2024 and is forecast to reach USD 359.03 million by 2032, at a CAGR of 4.1%. The Middle East represents a 3% market share. Saudi Arabia and the United Arab Emirates are leading adoption with growing investments in healthcare modernization and specialty care. Regional governments focus on increasing access to advanced neurological treatments and building comprehensive stroke centers. Efforts to train specialists and raise disease awareness are gradually enhancing device penetration. Import reliance and pricing pressures present challenges for broader market expansion.

Africa Neurovascular Devices Market

Africa Neurovascular Devices Market grew from USD 198.65 million in 2018 to USD 295.84 million in 2024 and is estimated to reach USD 343.64 million by 2032, showing a CAGR of 1.0%. Africa accounts for a 3% market share. South Africa, Egypt, and Nigeria are primary markets, although access to advanced neurovascular care remains limited. Public sector initiatives are aiming to improve diagnosis and treatment, while partnerships with international organizations are helping to train healthcare professionals. Device adoption is slow due to budget constraints, infrastructure gaps, and a shortage of specialized facilities. Companies are focusing on long-term market education and local partnerships to support future growth.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key Player Analysis

  • Medtronic
  • Stryker Corporation
  • Terumo Corporation
  • Penumbra, Inc.
  • Johnson & Johnson Services, Inc.
  • Integra LifeSciences Corporation
  • Acandis GmbH
  • Spiegelberg GmbH & Co. KG
  • MicroPort Scientific Corporation
  • ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

Competitive Analysis

The competitive landscape of the Neurovascular Devices Market features prominent players such as Medtronic, Stryker Corporation, Terumo Corporation, Penumbra, Inc., Johnson & Johnson Services, Inc., Integra LifeSciences Corporation, Acandis GmbH, Spiegelberg GmbH & Co. KG, MicroPort Scientific Corporation, and ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. These companies maintain their leadership through robust research and development efforts, consistent product launches, and a focus on technological innovation. Companies compete by expanding their product portfolios and securing regulatory approvals for next-generation neurovascular solutions, such as minimally invasive devices and AI-powered imaging tools. Strategic mergers, acquisitions, and collaborations with academic institutions and hospitals play a crucial role in expanding geographic presence and accelerating time-to-market for new products. The industry also emphasizes clinical research to demonstrate the effectiveness and safety of their devices, which supports widespread clinical adoption. Global and regional firms are focusing on addressing unmet clinical needs and tailoring solutions to specific market demands, especially in fast-growing regions. Competitive intensity continues to rise, driven by the ongoing pursuit of technological leadership and broader access to neurovascular care.

Recent Developments

  • In September 2024, CERENOVUS, Inc. launched a next-generation balloon guide catheter, EMBOGUARD, for treating patients suffering from acute ischemic stroke.
  • In June 2024, Terumo Corporation introduced the LVIS EVO Intraluminal Support Device for treating wide-neck intracranial aneurysms in the U.S. market.
  • In May 2024, Penumbra, Inc. reported the CE Mark authorization and the launch of three of its neurovascular reperfusion catheters in Europe- Red 78, Red 43, and Red 72 with SENDit Technology  for treating acute ischemic strokes.
  • In April 2024, CERENOVUS, Inc., launched the CEREGLIDE 71 Aspiration Catheter in Europe; this catheter is useful for revascularizing patients suffering from acute ischemic stroke.
  • In September 2023, Terumo Corporation obtained 510(k) clearance from the FDA for its Sofia EX 5Fr 115cm intracranial support catheter for use in trans-radial access.

Market Concentration & Characteristics

The Neurovascular Devices Market displays a moderate to high level of market concentration, with a few large multinational companies holding significant influence due to extensive product portfolios, established distribution networks, and continuous innovation. It features a strong focus on advanced technology, including minimally invasive devices and integration with digital health solutions. The market is characterized by rapid adoption of new products, rigorous regulatory standards, and high investment in clinical research. Barriers to entry remain considerable because of strict approval processes and the need for substantial capital investment. It experiences ongoing consolidation, with mergers, acquisitions, and strategic partnerships frequently shaping competitive dynamics. Companies compete on technological leadership, clinical evidence, and global reach, while regional players contribute to market diversity by introducing cost-effective and locally tailored solutions. The sector prioritizes safety, efficacy, and clinician training, reflecting its commitment to quality outcomes and sustainable growth.

Report Coverage

The research report offers an in-depth analysis based on Device, Application, End-use, Size and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

  1. Demand for personalized neurovascular devices will rise, driven by advances in genomics and precision medicine.
  2. Digital health integration will expand, supporting remote patient monitoring and real-time data sharing between providers and patients.
  3. Artificial intelligence applications will increase, enabling faster diagnosis and optimized treatment pathways in neurovascular care.
  4. Growing awareness and education programs will improve early detection and timely intervention for neurovascular diseases worldwide.
  5. Industry leaders will prioritize eco-friendly manufacturing and sustainable product designs to align with global environmental goals.
  6. Expanded training and education for healthcare professionals will enhance the adoption and safe use of advanced neurovascular devices.
  7. Increasing clinical trial activity will strengthen evidence for novel technologies and support broader market access.
  8. Companies will focus on developing cost-effective devices to improve affordability and access in lower-income and rural regions.
  9. Partnerships with academic and research organizations will accelerate innovation and bring new device concepts to commercialization.
  10. Evolving reimbursement frameworks and health policy reforms will support broader insurance coverage for neurovascular procedures, encouraging market growth.

CHAPTER NO. 1 : GENESIS OF THE MARKET
1.1 Market Prelude – Introduction & Scope
1.2 The Big Picture – Objectives & Vision
1.3 Strategic Edge – Unique Value Proposition
1.4 Stakeholder Compass – Key Beneficiaries
CHAPTER NO. 2 : EXECUTIVE LENS
2.1 Pulse of the Industry – Market Snapshot
2.2 Growth Arc – Revenue Projections (USD Million)
2.3. Premium Insights – Based on Primary Interviews
CHAPTER NO. 3 : NEUROVASCULAR DEVICES MARKET FORCES & INDUSTRY PULSE
3.1 Foundations of Change – Market Overview
3.2 Catalysts of Expansion – Key Market Drivers
3.2.1 Momentum Boosters – Growth Triggers
3.2.2 Innovation Fuel – Disruptive Technologies
3.3 Headwinds & Crosswinds – Market Restraints
3.3.1 Regulatory Tides – Compliance Challenges
3.3.2 Economic Frictions – Inflationary Pressures
3.4 Untapped Horizons – Growth Potential & Opportunities
3.5 Strategic Navigation – Industry Frameworks
3.5.1 Market Equilibrium – Porter’s Five Forces
3.5.2 Ecosystem Dynamics – Value Chain Analysis
3.5.3 Macro Forces – PESTEL Breakdown
3.6 Price Trend Analysis
3.6.1 Regional Price Trend
3.6.2 Price Trend by product
CHAPTER NO. 4 : KEY INVESTMENT EPICENTER
4.1 Regional Goldmines – High-Growth Geographies
4.2 Product Frontiers – Lucrative Product Categories
4.3 Application Sweet Spots – Emerging Demand Segments
CHAPTER NO. 5: REVENUE TRAJECTORY & WEALTH MAPPING
5.1 Momentum Metrics – Forecast & Growth Curves
5.2 Regional Revenue Footprint – Market Share Insights
5.3 Segmental Wealth Flow – Device & Application Revenue
CHAPTER NO. 6 : TRADE & COMMERCE ANALYSIS
6.1. Import Analysis by Region
6.1.1. Global Neurovascular Devices Market Import Volume By Region
6.2. Export Analysis by Region
6.2.1. Global Neurovascular Devices Market Export Volume By Region
CHAPTER NO. 7 : COMPETITION ANALYSIS
7.1. Company Market Share Analysis
7.1.1. Global Neurovascular Devices Market: Company Market Share
7.1. Global Neurovascular Devices Market Company Volume Market Share
7.2. Global Neurovascular Devices Market Company Revenue Market Share
7.3. Strategic Developments
7.3.1. Acquisitions & Mergers
7.3.2. New Product Launch
7.3.3. Regional Expansion
7.4. Competitive Dashboard
7.5. Company Assessment Metrics, 2024
CHAPTER NO. 8 : NEUROVASCULAR DEVICES MARKET – BY DEVICE SEGMENT ANALYSIS
8.1. Neurovascular Devices Market Overview by Device Segment
8.1.1. Neurovascular Devices Market Volume Share By Device
8.1.2. Neurovascular Devices Market Revenue Share By Device
8.2. Cerebral Embolization and aneurysm Coiling devices
8.3. Cerebral Angioplasty and Stenting Systems
8.4. Neurothrombectomy Devices
8.5. Support Devices
CHAPTER NO. 9 : NEUROVASCULAR DEVICES MARKET – BY APPLICATION SEGMENT ANALYSIS
9.1. Neurovascular Devices Market Overview by Application Segment
9.1.1. Neurovascular Devices Market Volume Share By Application
9.1.2. Neurovascular Devices Market Revenue Share By Application
9.2. Stroke
9.3. Cerebral Artery Stenosis
9.4. Cerebral Aneurysm
9.5. Others
CHAPTER NO. 10 : NEUROVASCULAR DEVICES MARKET – BY END-USE SEGMENT ANALYSIS
10.1. Neurovascular Devices Market Overview by End-use Segment
10.1.1. Neurovascular Devices Market Volume Share By End-use
10.1.2. Neurovascular Devices Market Revenue Share By End-use
10.2. Hospitals
10.3. Specialty Clinics
10.4. Others
CHAPTER NO. 11 : NEUROVASCULAR DEVICES MARKET – BY SIZE SEGMENT ANALYSIS
11.1. Neurovascular Devices Market Overview by Size Segment
11.1.1. Neurovascular Devices Market Volume Share By Size
11.1.2. Neurovascular Devices Market Revenue Share By Size
11.2. 0.027″
11.3. 0.021″
11.4. 0.071″
11.5. 0.017″
11.6. 0.019″
11.7. 0.013″
11.8. 0.058″
11.9. 0.068″
11.10. Others
CHAPTER NO. 12 : NEUROVASCULAR DEVICES MARKET – REGIONAL ANALYSIS
12.1. Neurovascular Devices Market Overview by Region Segment
12.1.1. Global Neurovascular Devices Market Volume Share By Region
12.1.2. Global Neurovascular Devices Market Revenue Share By Region
12.1.3. Regions
12.1.4. Global Neurovascular Devices Market Volume By Region
12.1.5. Global Neurovascular Devices Market Revenue By Region
12.1.6. Device
12.1.7. Global Neurovascular Devices Market Volume By Device
12.1.8. Global Neurovascular Devices Market Revenue By Device
12.1.9. Application
12.1.10. Global Neurovascular Devices Market Volume By Application
12.1.11. Global Neurovascular Devices Market Revenue By Application
12.1.12. End-use
12.1.13. Global Neurovascular Devices Market Volume By End-use
12.1.14. Global Neurovascular Devices Market Revenue By End-use
12.1.12. Size
12.1.13. Global Neurovascular Devices Market Volume By Size
12.1.14. Global Neurovascular Devices Market Revenue By Size
CHAPTER NO. 13 : NORTH AMERICA NEUROVASCULAR DEVICES MARKET – COUNTRY ANALYSIS
13.1. North America Neurovascular Devices Market Overview by Country Segment
13.1.1. North America Neurovascular Devices Market Volume Share By Region
13.1.2. North America Neurovascular Devices Market Revenue Share By Region
13.2. North America
13.2.1. North America Neurovascular Devices Market Volume By Country
13.2.2. North America Neurovascular Devices Market Revenue By Country
13.2.3. Device
13.2.4. North America Neurovascular Devices Market Volume By Device
13.2.5. North America Neurovascular Devices Market Revenue By Device
13.2.6. Application
13.2.7. North America Neurovascular Devices Market Volume By Application
13.2.8. North America Neurovascular Devices Market Revenue By Application
13.2.9. End-use
13.2.10. North America Neurovascular Devices Market Volume By End-use
13.2.11. North America Neurovascular Devices Market Revenue By End-use
13.2.12. Size
13.2.13. North America Neurovascular Devices Market Volume By Size
13.2.14. North America Neurovascular Devices Market Revenue By Size
13.3. U.S.
13.4. Canada
13.5. Mexico
CHAPTER NO. 14 : EUROPE NEUROVASCULAR DEVICES MARKET – COUNTRY ANALYSIS
14.1. Europe Neurovascular Devices Market Overview by Country Segment
14.1.1. Europe Neurovascular Devices Market Volume Share By Region
14.1.2. Europe Neurovascular Devices Market Revenue Share By Region
14.2. Europe
14.2.1. Europe Neurovascular Devices Market Volume By Country
14.2.2. Europe Neurovascular Devices Market Revenue By Country
14.2.3. Device
14.2.4. Europe Neurovascular Devices Market Volume By Device
14.2.5. Europe Neurovascular Devices Market Revenue By Device
14.2.6. Application
14.2.7. Europe Neurovascular Devices Market Volume By Application
14.2.8. Europe Neurovascular Devices Market Revenue By Application
14.2.9. End-use
14.2.10. Europe Neurovascular Devices Market Volume By End-use
14.2.11. Europe Neurovascular Devices Market Revenue By End-use
14.2.12. Size
14.2.13. Europe Neurovascular Devices Market Volume By Size
14.2.14. Europe Neurovascular Devices Market Revenue By Size
14.3. UK
14.4. France
14.5. Germany
14.6. Italy
14.7. Spain
14.8. Russia
14.9. Rest of Europe
CHAPTER NO. 15 : ASIA PACIFIC NEUROVASCULAR DEVICES MARKET – COUNTRY ANALYSIS
15.1. Asia Pacific Neurovascular Devices Market Overview by Country Segment
15.1.1. Asia Pacific Neurovascular Devices Market Volume Share By Region
15.1.2. Asia Pacific Neurovascular Devices Market Revenue Share By Region
15.2. Asia Pacific
15.2.1. Asia Pacific Neurovascular Devices Market Volume By Country
15.2.2. Asia Pacific Neurovascular Devices Market Revenue By Country
15.2.3. Device
15.2.4. Asia Pacific Neurovascular Devices Market Volume By Device
15.2.5. Asia Pacific Neurovascular Devices Market Revenue By Device
15.2.6. Application
15.2.7. Asia Pacific Neurovascular Devices Market Volume By Application
15.2.8. Asia Pacific Neurovascular Devices Market Revenue By Application
15.2.9. End-use
15.2.10. Asia Pacific Neurovascular Devices Market Volume By End-use
15.2.11. Asia Pacific Neurovascular Devices Market Revenue By End-use
15.2.12. Size
15.2.13. Asia Pacific Neurovascular Devices Market Volume By Size
15.2.14. Asia Pacific Neurovascular Devices Market Revenue By Size
15.3. China
15.4. Japan
15.5. South Korea
15.6. India
15.7. Australia
15.8. Southeast Asia
15.9. Rest of Asia Pacific
CHAPTER NO. 16 : LATIN AMERICA NEUROVASCULAR DEVICES MARKET – COUNTRY ANALYSIS
16.1. Latin America Neurovascular Devices Market Overview by Country Segment
16.1.1. Latin America Neurovascular Devices Market Volume Share By Region
16.1.2. Latin America Neurovascular Devices Market Revenue Share By Region
16.2. Latin America
16.2.1. Latin America Neurovascular Devices Market Volume By Country
16.2.2. Latin America Neurovascular Devices Market Revenue By Country
16.2.3. Device
16.2.4. Latin America Neurovascular Devices Market Volume By Device
16.2.5. Latin America Neurovascular Devices Market Revenue By Device
16.2.6. Application
16.2.7. Latin America Neurovascular Devices Market Volume By Application
16.2.8. Latin America Neurovascular Devices Market Revenue By Application
16.2.9. End-use
16.2.10. Latin America Neurovascular Devices Market Volume By End-use
16.2.11. Latin America Neurovascular Devices Market Revenue By End-use
16.2.12. Size
16.2.13. Latin America Neurovascular Devices Market Volume By Size
16.2.14. Latin America Neurovascular Devices Market Revenue By Size
16.3. Brazil
16.4. Argentina
16.5. Rest of Latin America
CHAPTER NO. 17 : MIDDLE EAST NEUROVASCULAR DEVICES MARKET – COUNTRY ANALYSIS
17.1. Middle East Neurovascular Devices Market Overview by Country Segment
17.1.1. Middle East Neurovascular Devices Market Volume Share By Region
17.1.2. Middle East Neurovascular Devices Market Revenue Share By Region
17.2. Middle East
17.2.1. Middle East Neurovascular Devices Market Volume By Country
17.2.2. Middle East Neurovascular Devices Market Revenue By Country
17.2.3. Device
17.2.4. Middle East Neurovascular Devices Market Volume By Device
17.2.5. Middle East Neurovascular Devices Market Revenue By Device
17.2.6. Application
17.2.7. Middle East Neurovascular Devices Market Volume By Application
17.2.8. Middle East Neurovascular Devices Market Revenue By Application
17.2.9. End-use
17.2.10. Middle East Neurovascular Devices Market Volume By End-use
17.2.11. Middle East Neurovascular Devices Market Revenue By End-use
17.2.12. Size
17.2.13. Middle East Neurovascular Devices Market Volume By Size
17.2.14. Middle East Neurovascular Devices Market Revenue By Size
17.3. GCC Countries
17.4. Israel
17.5. Turkey
17.6. Rest of Middle East
CHAPTER NO. 18 : AFRICA NEUROVASCULAR DEVICES MARKET – COUNTRY ANALYSIS
18.1. Africa Neurovascular Devices Market Overview by Country Segment
18.1.1. Africa Neurovascular Devices Market Volume Share By Region
18.1.2. Africa Neurovascular Devices Market Revenue Share By Region
18.2. Africa
18.2.1. Africa Neurovascular Devices Market Volume By Country
18.2.2. Africa Neurovascular Devices Market Revenue By Country
18.2.3. Device
18.2.4. Africa Neurovascular Devices Market Volume By Device
18.2.5. Africa Neurovascular Devices Market Revenue By Device
18.2.6. Application
18.2.7. Africa Neurovascular Devices Market Volume By Application
18.2.8. Africa Neurovascular Devices Market Revenue By Application
18.2.9. End-use
18.2.10. Africa Neurovascular Devices Market Volume By End-use
18.2.11. Africa Neurovascular Devices Market Revenue By End-use
18.2.12. Size
18.2.13. Africa Neurovascular Devices Market Volume By Size
18.2.14. Africa Neurovascular Devices Market Revenue By Size
18.3. South Africa
18.4. Egypt
18.5. Rest of Africa
CHAPTER NO. 19 : COMPANY PROFILES
19.1. Medtronic
19.1.1. Company Overview
19.1.2. Product Portfolio
19.1.3. Financial Overview
19.1.4. Recent Developments
19.1.5. Growth Strategy
19.1.6. SWOT Analysis
19.2. Stryker Corporation
19.3. Terumo Corporation
19.4. Penumbra, Inc.
19.5. Johnson & Johnson Services, Inc.
19.6. Integra LifeSciences Corporation
19.7. Acandis GmbH
19.8. Spiegelberg GmbH & Co. KG
19.9. MicroPort Scientific Corporation
19.10. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

Frequently Asked Question:

What is the current size of the Neurovascular Devices Market?

What is the current size of the Neurovascular Devices Market?The Neurovascular Devices Market is valued at USD 7,851.39 million in 2024 and is expected to reach USD 12,298.26 million by 2032.

What factors are driving the growth of the Neurovascular Devices Market?

Growth is driven by the rising incidence of neurovascular diseases, advancements in minimally invasive devices, and increased healthcare investments.

What are some challenges faced by the Neurovascular Devices Market?

Challenges include high device costs, strict regulatory requirements, and limited access to specialized care in some regions.

Who are the major players in the Neurovascular Devices Market?

Major players include Medtronic, Stryker Corporation, Terumo Corporation, Penumbra, Inc., and Johnson & Johnson Services, Inc.

Who are the major players in this market?

Terumo Corporation, Merit Medical Systems, Inc., W. L. Gore & Associates, Inc., Johnson & Johnson, MicroPort Scientific Corporation, Delaware Corporation, Rapid Medical, Medtronic plc. are some of the major players in the global market.

About Author

Shweta Bisht

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Gunakesh Parmar

Reviewed By
Gunakesh Parmar

Research Consultant

With over 15 years of dedicated experience in market research since 2009, specializes in delivering actionable insights from data.

View Profile

Neurovascular Stent Retrievers Market

Published:
Report ID: 69458

Neurovascular Thrombectomy Device Market

Published:
Report ID: 35073

Neurovascular Guidewires Market

Published:
Report ID: 14454

Peripheral Micro Catheters Market

Published:
Report ID: 76238

Coil Assisted Flow Diverters Market

Published:
Report ID: 69333

Micro Guide Catheters Market

Published:
Report ID: 48929

Germany Guidewires Market

Published:
Report ID: 33962

Bowel Management Systems Market

Published:
Report ID: 3440

Platelet Incubators Market

Published:
Report ID: 9757

Patient Warming Systems Market

Published:
Report ID: 8931

Medical Dynamometers Market

Published:
Report ID: 8914

Hemodialysis Vascular Grafts Market

Published:
Report ID: 6457

Airway Management Devices Market

Published:
Report ID: 1355

Veterinary Pain Management Market

Published:
Report ID: 11828

Anti-aging Services Market

Published:
Report ID: 12730

Vaginal Slings Market

Published:
Report ID: 11409

Oxygen Concentrators Market

Published:
Report ID: 8399

Amniocentesis Needles Market

Published:
Report ID: 12678

Angiography Equipment Market

Published:
Report ID: 12820

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$4699

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$5699

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
$12699

Credence Staff 3

WILLIAM, North America

Support Staff at Credence Research

KEITH PHILLIPS, Europe

Lee - CR Sales Staff

LEE VALLANCE, Asia Pacific

Smallform of Sample request

Report delivery within 24 to 48 hours

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN

Request Sample